PTEN loss was, in fact, a better predictor of resistance to A66, which is consistent with previous studies in other tumour types where knockdown on PIK3CA did not affect PI3K signalling in several PTEN null cancer lines [54]. This evidence concerns the gene PTEN and cancer.